Hypericin

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Drug Information

Target Indication

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNGX

Soligenix, Inc.

Related Pipeline

Cutaneous T-Cell Lymphoma

Oral Mucositis

Enteritis

Behçet Disease

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts